BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 19100320)

  • 1. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications.
    Tsukada Y; Hara K; Bando Y; Huang CC; Kousaka Y; Kawashima Y; Morishita R; Tsujimoto H
    Int J Pharm; 2009 Mar; 370(1-2):196-201. PubMed ID: 19100320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods.
    Kawashima Y; Yamamoto H; Takeuchi H; Hino T; Niwa T
    Eur J Pharm Biopharm; 1998 Jan; 45(1):41-8. PubMed ID: 9689534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
    Yin J; Noda Y; Yotsuyanagi T
    Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adriamycin release from self-assembling nanospheres of poly(DL-lactide-co-glycolide)-grafted pullulan.
    Jeong YI; Na HS; Oh JS; Choi KC; Song CE; Lee HC
    Int J Pharm; 2006 Sep; 322(1-2):154-60. PubMed ID: 16891068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV; Olivier JC
    Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system.
    Tahara K; Furukawa S; Yamamoto H; Kawashima Y
    Int J Pharm; 2010 Jun; 392(1-2):311-3. PubMed ID: 20347023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-in-water emulsion method.
    Mok H; Park TG
    Eur J Pharm Biopharm; 2008 Jan; 68(1):105-11. PubMed ID: 17870446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
    Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique.
    Ito F; Fujimori H; Honnami H; Kawakami H; Kanamura K; Makino K
    Colloids Surf B Biointerfaces; 2008 Oct; 66(1):65-70. PubMed ID: 18585903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres.
    Takashima Y; Saito R; Nakajima A; Oda M; Kimura A; Kanazawa T; Okada H
    Int J Pharm; 2007 Oct; 343(1-2):262-9. PubMed ID: 17628365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
    Mukerjee A; Vishwanatha JK
    Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
    Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y
    Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An innovative, quick and convenient labeling method for the investigation of pharmacological behavior and the metabolism of poly(DL-lactide-co-glycolide) nanospheres.
    Stevanović M; Maksin T; Petković J; Filipic M; Uskoković D
    Nanotechnology; 2009 Aug; 20(33):335102. PubMed ID: 19636100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery.
    Tahara K; Yamamoto H; Kawashima Y
    Eur J Pharm Biopharm; 2010 Jun; 75(2):218-24. PubMed ID: 20332026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of microfluidization parameters on the physical properties of PEG-PLGA nanoparticles prepared using high pressure microfluidization.
    Sani SN; Das NG; Das SK
    J Microencapsul; 2009 Sep; 26(6):556-61. PubMed ID: 18946802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled assembly of poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres under ultrasonic irradiation.
    Jevtić M; Radulović A; Ignjatović N; Mitrić M; Uskoković D
    Acta Biomater; 2009 Jan; 5(1):208-18. PubMed ID: 18753023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
    Della Porta G; Reverchon E
    Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.